Navigation Links
Data Published in Plastic and Reconstructive Surgery Show Cohera Medical's Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model
Date:6/19/2008

PITTSBURGH, June 19 /PRNewswire/ -- Cohera Medical Inc. today announced that data published in the July issue of Plastic and Reconstructive Surgery show the company's surgical adhesive, TissuGlu, was effective in preventing the formation of seroma in an animal abdominoplasty model.

Summarized in a paper titled "Lysine-Derived Urethane Surgical Adhesive Prevents Seroma Formation in a Canine Abdominoplasty Model," (Plast. Reconstr. Surg. 2008; Vol. 122, Issue 1: 95-102) the results demonstrated that TissuGlu successfully prevented the formation of seroma in a novel large-animal model designed to evaluate seroma formation. While the control side in all seven animals used in the study demonstrated large, clinically significant seromas, the side treated with TissuGlu showed little or no evidence of fluid accumulation. In addition, histologic analysis of tissue samples from the animals showed no signs of inflammation or foreign body reaction associated with the adhesive.

"I am impressed with the experimental data that demonstrate a clear ability of the adhesive to control seroma formation in this animal model," said J. Peter Rubin, M.D., founder and director of the Life After Weight Loss surgical body contouring program at the University of Pittsburgh and the lead author of the paper. "This adhesive shows strong potential for widespread applications in many surgical specialties."

Surgeons have expressed a strong need for a product that adheres tissue flaps to help prevent the fluid accumulation that occurs between tissue layers after surgery. Surgical adhesives available today fall into two categories: "superglue"-type products that are strong but cannot be used inside the body because they break down into toxic byproducts and "fibrin sealant" products that are biocompatible but create a weak bond and are expensive and difficult to prepare during surgery.

"Seromas have been a major problem for post-surgical patients," said Susan E. Downe
'/>"/>

SOURCE Cohera Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Long-term safety data on Lialda published in leading GI journal
2. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
3. New Regulations for Hospice Provision Published by CMS
4. First Comprehensive Reference on Evidence-Based Design Published
5. Premier issue of Environmental Justice just published
6. Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal
7. Castle Connollys Long Islands Top Doctors Published in Newsday Generates More Than 1.1 Million Views of Top Doctors Profiles in Single Day
8. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
9. 20th Edition of the Encyclopedia of Social Work Published
10. Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM
11. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)...AFFHAUSEN, Switzerland, Nov. 10 /PRNewswire-FirstC...nts) , , Q4 2009 Q4 2008 ... ------- ------- -------- ------- ----...284 (16)% $17,237 $20,199 (15)%, Inco... $207 $264 (22)% ($1,833) $1,095...
(Date:11/10/2009)... ANGELES, Nov. 10 Research conduct... Inc. (CARD), shines new light on the effects of a...treatment for children with autism and related dis... Therapy for Children with Autism" study reveals t...3 atmospheres of pressure, does not have a signifi...
(Date:11/10/2009)...he science is in place. Why are so many suffering?...swire/ -- Pain medicine physicians from the Americ...vance the call for better pain care as they joined... a closed-door National Pain Summit that took plac... Texas. ,, AAPM leaders have been vigilant in...
(Date:11/10/2009)...VARD, N.C., Nov. 10 Gaia Herbs, a ...anic herbal products, announces Quick Defense Liqu...ic Echinacea, organic Elderberry, organic Ginger a...ne system at onset. Working synergistically, the b... used for short periods of time during sinus and r...
(Date:11/10/2009)... The "Think Outside the Box&q...in health reform is to have policyholders select a...on or a plan which does not. , ...Saturday’s near-derailment of comprehensive ...bility that the same thing could happen again in t...
Breaking Medicine News(10 mins):Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 2Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 3Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 4Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 5Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 6Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 7Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 8Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 9Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 10Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 11Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 12Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 13Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 14Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 15Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 16Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 17Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 18Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 19Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 20Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 21Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 22Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 23Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 24Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 25Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 26Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 27Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 28Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 29Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 30Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 31Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 32Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 33Health News:Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism 2Health News:'The Time is Now for Better Pain Care for Patients' - Physician Leaders from Across Medicine Conclude from a Closed-Door Pain Summit 2Health News:'The Time is Now for Better Pain Care for Patients' - Physician Leaders from Across Medicine Conclude from a Closed-Door Pain Summit 3
...at exercise could benefit both the young and the o...n that exercise not only helps the elderly in prot... function, thus reducing the risk of Upper Respira... and a frequent problem in the ambulatory setting....
...ich is a serious problem in people with cancer, AI...iver, lungs and heart. A recent study has found th...d in fruit flies, where it is involved in muscle d...ce. Mice that were genetically modified to lack th...
... Carolina in Chapel Hill that was published in the...suggests that two genes - C282Y and H63D, which ar...osis may also lead to an increased risk of develop...re matched with healthy controls. Researchers also...
...y in a hospital in Switzerland who investigated w...tory prostate cancer could be measured via changes...state cancer doubling time may be an auxiliary mar...efractory prostate cancer and bi-dimensionally mea...
...fts University in Boston has revealed that childre...ions displayed on television. They also use emotio...to make decisions. Donna Mumme, assistant pro...holder, a blue bumpy ball, and a yellow garden hos...
...otechnology outlines a new method developed by Mic...nes required for the production of industrial mole... in the company's ability to improve the propertie...mize a cell's metabolic potential to increase prod...
Other Medicine News:
(Date:11/10/2009)...IA, November 10 , ... of Excellence in Serving,Healthcare Needs of Pati...,Michigan and Ohio , Elsevier ( http://w...d,medical publishing and online solutions, today a...health.org ), the nation,s fourth largest Catholic...
(Date:11/10/2009)...0 Despite the global economic decl...such as Poland, the Czech Republic, Slovakia, Hung...ctive healthcare market. Both the pharmaceutical a...ped to their full potential, with healthcare expen...mportance of this market is attracting multination...
(Date:11/10/2009).... 10 /PRNewswire/ -- JumpStart Inc., the Northea...lerates the progress of high growth early-stage bu...t commitment of $250,000 in Checkpoint Surgical, L...OH medical device company is developing and commer...mulator. ,, (Logo: http://www.newscom.com/cg...
Breaking Medicine Technology:Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 3Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 4Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan 2Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan 3JumpStart Invests in Checkpoint Surgical 2JumpStart Invests in Checkpoint Surgical 3APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 1APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 2Lifting weights reduces lymphedema symptoms following breast cancer surgery Penn research shows 54380 1Lifting weights reduces lymphedema symptoms following breast cancer surgery Penn research shows 54380 2Lifting weights reduces lymphedema symptoms following breast cancer surgery Penn research shows 54380 3Statement from the American College of Surgeons Regarding Recent Comments from President Obama 54376 1Statement from the American College of Surgeons Regarding Recent Comments from President Obama 54376 2
...ss.--(BUSINESS WIRE)--Mar 26, 2007 - CombinatoRx,...inary results of,a phase 2 clinical trial studying...olone and the antidepressant paroxetine),and 3mg p...hritis,(RA). This trial served two important purpo...g of prednisolone alone (a very low dose),in RA an...
...tudy in Seventy Type 2 Diabetes Patients -, MONT...nc.,(TSX:CJB) today announced positive prelimina...nical study for the treatment of Type 2,diabetes...n-4.,Results from the study demonstrated that PC...and, when administered once-weekly at each,of th...
Other Medicine Technology:CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 2CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 3CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 4CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 5CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 6PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 2PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 3PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 4
ACCUTEST H. pylori Test (Whole Blood)
OraQuick Rapid HIV-1 Antibody Test
...ous Mononucleosis test is designed to detect the I...e blood. The QuickVue+ Infectious Mononucleosis as...ch give a greater sensitivity and specificity than...ythrocytes. QuickVue+ Infectious Mononucleosis is ...
...irst available point-of-care diagnostic test that ...nfluenza A and B. The test uses a unique substrate...ts viral replication by promoting the release of t...te is labeled with a chromagen. When influenza vir...
Medicine Products: